The role of anions in the initiation of ischemia-and reperfusion-induced arrhythmias is unknown. We examined the antiarrhythmic effects of isotonic substitution of extracellular Cl-with N03-by using the rat Langendorff preparation (n = 12 per group). During 30 minutes of regional ischemia, the incidence of ventricular fibrillation (VF) was reduced from 50%o in hearts perfused with control solution (containing a Cl-:NO3 ratio of 100:0) to 25%, 0% (p<0.05), (p<0.05), and 0% (p<O.OS) by perfusion with solution containing Cl-:NO3-ratios of 75:25, 50:50, 25:75, and 0:100, respectively. The incidence of reperfusion-induced VF was also reduced from 58% to 25%, 8% (p<0.05), 8% (p<0.05), and 0%o (p<0.05), respectively. Similar effects were produced in hearts reperfused after briefer durations of ischemia (10 or 15 minutes). Substitution of NO3-for Cl-also facilitated spontaneous termination of VF. Heart rate and occluded zone size were not affected by anion manipulation. Coronary flow was affected by NO3-, but changes did not correlate with arrhythmias. During ischemia, electrocardiographic changes indicative of class III activity (widening of the ventricular complex) were produced by anion substitution. These changes occurred selectively in the ischemic tissue with no significant influence before ischemia onset. However, the relation between this effect and arrhythmia reduction was not linear and a cause-effect relation is therefore unlikely. In separate groups of hearts (n=12 per group), switching from 100:0 to 0:100 Cl-: NO3-solution or vice versa 10 seconds after coronary occlusion or just before reperfusion demonstrated that 1) protection against ischemia-induced VF resulted partly from an action in the ischemic zone and partly from an action in the nonischemic zone, and 2) protection against reperfusioninduced VF resulted principally from an action occurring during reperfusion and within the reperfused tissue. To assess whether benefit was offset by deleterious effects on contractile function in nonischemic tissue, we constructed Starling curves in isolated rat hearts. The 0:100 Cl-: N03-solution had no effect on compliance or contractility at physiological end-diastolic pressures but reduced the slope of the peak systolic pressure-volume relation by -20% as end-diastolic pressure was increased above 10 mm Hg. In conclusion, anions appear to play a hitherto unrecognized role in arrhythmogenesis in ischemia and reperfusion. Manipulation of anion homeostasis may represent a novel target for antiarrhythmic drug development. (Circulation Research 1992;70:617-632) 
known to be of benefit against ischemia-induced arrhythmias. 5 Although the role of reperfusion-induced VF in sudden death is not established, it is recognized that spontaneous reperfusion (occurring, for example, in vasospasm) is capable of eliciting VF in humans. 6 For these reasons, it would be advantageous if novel means for prevention of reperfusion-induced VF could be developed.
Modification of cation homeostasis has proven a logical target for intervention in the setting of ischemia and reperfusion. Ischemia-induced arrhythmias are susceptible to inhibition by drugs that inhibit sodium, calcium, and potassium currents,2 and reperfusion-induced arrhythmias can be attenuated by lowering extracellular calcium concentration7 or raising extracellular potassium concentration.8 However, little information is available concerning the antiarrhythmic potential of manipulation of anion homeostasis during ischemia or reperfusion. To our knowledge, the only relevant study concerns the activity of 4-acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic acid (SITS), a blocker of Cl-HCO3-exchange, which was found to inhibit ischemiainduced and reperfusion-induced arrhythmias. 9 In the present study we have attempted to examine whether manipulation of the anion content of the extracellular milieu is capable of inhibiting ischemiaand reperfusion-induced VF. This was achieved by replacing Cl-with NO3-in perfusion media. Possible indirect mechanisms responsible for any antiarrhythmic effects were evaluated by contiguous assessment of relevant antecedent hemodynamic and electrocardiographic variables. An attempt was made to determine the site of antiarrhythmic action against ischemia-induced arrhythmias (ischemic versus nonischemic tissue) and to discern whether any reduction in reperfusioninduced arrhythmias resulted from an action during reperfusion (direct action) or from an action during ischemia (indirect action) by crossover perfusion. Finally, to test whether any benefit was offset by potentially deleterious effects on contractility or compliance in nonischemic tissue, we measured systolic and diastolic function by constructing Starling curves in additional groups of hearts.
Materials and Methods

Animals and Experimental Methods
Male Wistar rats (220-260 g, Banting and Kingman) were anesthetized with diethyl ether, and 200 IU sodium heparin was administered intravenously. After 30 seconds each heart was quickly excised and immersed in ice-cold perfusion solution (constituents described below) to induce rapid arrest. The aorta was cannulated for Langendorff perfusion.10 A Ag-AgCI wire electrode was inserted into the left ventricular muscle mass (in the center of the region to become ischemic) to record a unipolar electrogram (ECG) that was recorded against a lead attached to the aortic cannula. This electrode arrangement gave a clear P wave and ventricular complex. The ECG was continuously displayed on a Gould pen recorder at 5 mm/sec chart speed and a Gould digital storage type 1421 oscilloscope at 100 mm/sec sweep speed. Permanent chart recordings at fast speed (100 mm/sec) were taken 1) periodically (for estimating arrhythmias, and 3) continuously for the period 10 seconds before the start of reperfusion until 3 minutes after the start of reperfusion. For studies of regional ischemia a traction-type coronary occluderll consisting of a silk suture threaded through a polyethylene guide cannula was used for coronary occlusion. The suture was positioned loosely around the left main coronary artery according to Heimburger'2 as modified for in vitro experimentation. 13 Each heart was allowed to stabilize for 10 minutes before coronary occlusion.
After the designated period of ischemia, the occluder was released and the heart was reperfused for 3 minutes. In some experiments global ischemia was used. This was achieved by occluding the aortic inflow line. To prevent sinus bradycardia during global ischemia. heart rate was maintained by atrial superfusion '4 Verification of Coronary Occlusion and Reperfusion Two independent methods were used to verify occlusion during regional ischemia and to delineate the ischemic (occluded zone) tissue from the nonischemic tissue, as described previously.8 First, coronary flow was recorded by timed collection of the coronary effluent and occlusion was verified by comparing flow 1 minute before occlusion with flow 1 minute after occlusion. Second, at the end of each experiment (3 minutes after the start of reperfusion) the perfusion solution was replaced by a solution of sulfan blue dye B.P.C. (Disulphine blue, ICI). Each heart received 5 ml diluted dye (500 mg in 1 1 0.9% saline), and the coronary occluder was retightened. Perfusion solution was then reintroduced for 3 minutes, leaving dye trapped in the occluded zone. After excision of the atria and excess mediastinal tissue, the occluded zone was dissected from the nondyed nonischemic zone. The occluded zone was weighed and quantified as a percentage of the total ventricular weight. Reperfusion was also verified by two independent methods, as described previously. all solutions. Throughout the text, "NO3-substitution for Cl-" has been abbreviated to "NCS."
Experimental Protocol
Concentration-response and time-response study. The severity of reperfusion-induced arrhythmias is highly dependent on the duration of preceding ischemia.1617
Some interventions, for example, manipulation of extracellular calcium,18 are known to confer benefit only when reperfusion takes place at specific times. We have therefore examined four durations of regional ischemia (5, 10, 15, and 30 minutes) in conjunction with each of the five solutions described above; thus, a total of 20 groups of hearts were used. Each heart was used only once, and 12 hearts were used per group as in previous studies8; thus a total of 240 hearts were used. We used hierarchical, nested, randomized block design, analogous to a Latin square within a Latin square'9 in the design of the study, as described previously.8 Five randomization tables were constructed. Each table contained four "experimental units" corresponding to the four ischemic durations arranged into 12 "blocks." The choice of solution was determined by reference to a sixth randomization table from which two solutions were chosen for each experimental run (typically eight rats). The experimental operator was blinded to the nature of the solution. Records were identified by a number code only, and therefore analysis was carried out without knowledge of the solution used. Codes were broken on completion of analysis. The group of hearts exposed to 30 minutes of regional ischemia was used for examining the effect of anion manipulation on susceptibility to ischemia-induced arrhythmias.
Crossover study with regional ischemia. With respect to ischemia-induced arrhythmias, if any protection were conferred by NCS in the foregoing protocol, it would not be possible to differentiate between an action on the ischemic versus the nonischemic zones. A second protocol was therefore used to resolve this question. Because collateral flow in the rat heart is less than 5%,20
we set out to trap either Cl-or NO3-solution in the ischemic zone with delivery of either solution to the adjacent nonischemic zone.
The outlets of two glass perfusion columns were connected inferiorly with a malleable plastic Y-connector, which delivered perfusate via a single aortic cannula to a heart that was perfused in the Langendorff mode. One column contained standard Cl--containing solution and the other column contained solution with complete Cl-substitution by NO3 . With this arrangement it was possible to rapidly switch the solution delivered to the heart by clamping one or other limb of the Y-connector and simultaneously declamping the other limb. The measured dead space was 0.2 ml. Coronary flow in perfused rat hearts before, during, and after regional ischemia ranges from approximately 4 to 18 ml/min.8 Thus, the lag time for complete exchange of coronary perfusion ranged between 0.67 and 3 seconds.
Four groups of 12 rats were studied. In each case a 10-minute period of control perfusion was followed by 30 minutes of regional ischemia. In the first group, after an initial 10-minute period of control perfusion with taining solution in the ischemic zone. Ten seconds after coronary occlusion the solution was replaced by Cl--containing solution (Cl-: NO3-ratio, 100: 0). The hearts continued to receive Cl--containing solution for the remainder of the 30-minute period of ischemia with delivery of Cl--containing solution to the nonischemic region. In the second group, Cl--containing solution was delivered during the 10-minute period of control perfusion and trapped in the ischemic zone after occlusion, in a manner equivalent to NO3-trapping in the first group. This was followed, 10 seconds after occlusion, by replacement of the Cl--containing solution with NO3--containing solution that was delivered throughout the remainder of the experiment. Thus, Cl--containing solution was trapped in the ischemic region while NO3--containing solution was delivered to the nonischemic region. In the third group, NO3--containing solution was delivered during the 10-minute period of control perfusion and during the 30-minute period of regional ischemia. Thus, NO3--containing solution was trapped in the ischemic region and was delivered to the nonischemic region. In the fourth group, Cl--containing solution was delivered during the 10-minute period of control perfusion and during the period of regional ischemia. Thus, Cl--containing solution was trapped in the ischemic region and was delivered to the nonischemic region. Hearts were randomized to treatment, and analysis of records was carried out blindly.
Crossover study with global ischemia. The arterial supply of the rat ventricle has been shown to possess few functional collaterals.20,21 However, even a small amount of collateral flow would lead to the possibility of contamination of solution trapped in the ischemic zone by the solution delivered to the nonischemic zone. To overcome this potential problem when examining reperfusion arrhythmias, we used a model of global ischemia.14 In this model, the variability of outcome of reperfusion encountered in some global ischemia models22 is overcome by the use of atrial superfusion; this effectively maintains ventricular temperature, sinus rate, and, most importantly, ventricular beating rate, at levels close to those encountered in regionally ischemic hearts.14 The result of this is an increase in the incidence of reperfusion-induced VF in control hearts to a level that resembles that observed in hearts reperfused after regional ischemia.'4 Two perfusion chambers filled with either 100:0 or 0:100 Cl: NO3-solutions were arranged with an inferiorly placed malleable plastic Y-connector so the solutions could be easily crossed over. Hearts were randomized to one of four groups. In the first group, Cl--containing solution was delivered during a 10-minute control period, which was followed by 10 minutes of global ischemia with continuous atrial superfusion. Each heart was then reperfused with Cl--containing solution. Thus, Cl--containing solution was trapped in the ischemic tissue and Cl--containing solution was delivered during reperfusion. In the second group, NO3--containing solution (Cl-: NO3-ratio, 0:100) was delivered during control perfusion (and trapped in the ischemic tissue) and also during reperfusion. In the third group, Cl--containing solution was used for the initial 10-minute control perfusion and was trapped in the heart during global ischemia, whereas NO3--containing solution was delivered during reperfusion. In the fourth group, NO3--containing solution was N03--containing solution (Cl-: N03-ratio, 0: 100), the left coronary artery was occluded trapping N03--con-delivered during the initial 10-minute control perfusion and trapped in the heart during global ischemia, whereas Cl--containing solution was delivered during reperfusion. Hearts were randomized to treatment, and analysis of records was carried out blindly.
It should be noted that we were unable to use the global ischemia model for crossover studies concerning ischemiainduced arrhythmias since an adjacent nonischemic zone is necessary for arrhythmogenesis in this setting. 
Exclusion Criteria
A total of 404 hearts, of which 336 were retained, were used for these studies. Sixty-eight preparations (17%) had to be excluded for reasons listed below.
Stability criteria. Unstable preparations were excluded. A stable preparation was defined as having (5 minutes before occlusion) a sinus rate of at least 290 beats per minute, a coronary flow of at least 9 ml/min, and an absence of arrhythmias. Stability criteria were not fulfilled by five hearts.
Ventricular rate (in the global ischemia group). Any heart with a ventricular rate less than 150 beats per minute 9 minutes after the beginning of global ischemia and 1 minute before reperfusion was excluded in accordance with previous observations in this model in which it was found that in control hearts this criterion was absolutely essential for occurrence of reperfusion-in- reperfusion study and replaced, as described previously,14 since it would have been impossible to determine whether ischemia or reperfusion was responsible for arrhythmias occurring during reperfusion. The resultant censoring and selection generated three subsets of hearts: 1) a subset suitable for the study of ischemiainduced arrhythmias (the hearts used in the first attempt to fill each "cell" of the randomization table, some of which were not in sinus rhythm at the time of reperfusion); 2) a subset suitable for the study of reperfusion-induced arrhythmias (the hearts that were in sinus rhythm at the moment of reperfusion); and 3) all hearts entered into the study.
Measurement of Contractile Function
Many antiarrhythmic agents have negative inotropic actions that detract from their therapeutic efficacy. 28 Evidence from studies in isolated myocardial tissue preparations suggests that substitution of Cl-for other anions may actually be positively inotropic.29-3' To determine whether any antiarrhythmic effects of NCS were offset by impairment of contractility in the nonischemic (uninvolved) region, we evaluated isochoric left ventricular systolic and diastolic function in separate groups of rat hearts perfused in the Langendorff mode.
A small compliant, but nonelastic, balloon was made from plastic wrapping film (Clingfilm) and connected via a length of polypropylene tube to a pressure transducer (Spectramed P23XL, Statham, UK). The balloon was made slightly more capacious than the left ventricle (typically 0.4 ml) to ensure that, as it was filled, any increase in the measured pressure was caused by an increase in ventricular wall tension and not balloon wall tension.32 An opening was cut in the left atrium and used for insertion of the balloon catheter into the left ventricle. The catheter was inflated with distilled water. With the balloon inflated, isochoric pressure recordings of left ventricular systolic and diastolic pressures were made before and after intervention.
A total of four solutions were used: standard Clcontaining solution or solution modified by complete NCS or by addition of 10 ,M epinephrine or 1 ,uM verapamil. The latter two interventions were used as standards for testing the sensitivity of the preparation as a model for detecting negative and positive inotropic activity and for gauging the extent of any effects of NO3-.
A randomized design was used, and nine hearts were used for each intervention. After 15 minutes of control perfusion with standard Cl--containing solution (during which time the intraventricular balloon was inserted), isochoric ventricular pressure was measured. A Starling curve was constructed with 10-pl volume increments to the balloon.32 The volume required to achieve a diastolic pressure of 10 mm Hg under these baseline conditions (vollo) was noted, and the ventricle was then unloaded by deflation of the balloon. Ten minutes later, the solution was switched either to an identical Cl--containing solution (time-matched control group) or to one of the three interventions. After 15 minutes the balloon was reinflated to vollo, and then the Starling curve was reevaluated.
For this study, a stable preparation was defined as having (at the end of the initial perfusion with control solution) a sinus rate of at least 290 beats per minute, a coronary flow of at least 9 ml/min, and a developed pressure (systolic minus diastolic) of greater than 100 mm Hg at vollo. Stability criteria resulted in the exclusion of five hearts of an original 41 entered into the study.
There is evidence that the slope of the peak isochoric pressure-volume relation (EES) is a useful measure of left ventricular systolic function. 33 We determined EES as a best-fit linear regression line. A second measure of systolic function (contractility) was calculated as the systolic minus diastolic ("developed") pressure.32 This variable, determined at a "high physiological" end-diastolic pressure (10 mm Hg), was presented to put into perspective any changes occurring in EES, since it was expected that determination of EES would require incrementation of end-diastolic pressure beyond the range normally encountered in the heart in vivo.
Isochoric diastolic pressure is determined in part by left ventricular diastolic compliance (e.g., Reference 34). To gain a measure of any change in compliance we recorded the diastolic pressure at vollo (i.e., using the same intraventricular volume that produced a diastolic pressure of 10 mm Hg during the control perfusion).
All values were expressed as mean±SEM. Groups were compared by modified parametric analysis (see below), which was paired when values were compared before and after switching solutions.
Statistics
Statistical analyses were based on previously published guidelines.24,35 Gaussian-distributed variables (which included heart rate, coronary flow, and indexes of contractile function) were expressed as mean±SEM and were subjected to analysis of variance. If treatment constituted a significant source of variance, each group of hearts with differing Cl-: NO3-ratios was compared with the control standard Cl--only group by using Dunnett's test. Data transformation was necessary to permit analysis of means for variables not Gaussian distributed. The duration of VT, the number of VPBs, and the time of onset of first reperfusion-induced arrhythmia are logl0 Gaussian distributed and were therefore logl0-transformed, as described previously. 8, 27, 36 Only those hearts that exhibited particular rhythm disturbances were used in the calculation of mean±SEM values for variables such as log10 onset time. Group percent incidences of arrhythmias were compared using Mainland's contingency tables.37 We took p<0.05 to indicate a statistically significant effect.
Results
Ischemia-Induced Arrhythmias
Statistically significant concentration-dependent reductions in the incidences of ischemia-induced arrhythmias were produced by NCS. The incidence of VF was reduced by 50% by perfusion with solution containing a Cl-: NO3-ratio of 75:25; thus, only a modest NCS produced a large antiarrhythmic effect. Higher proportions of NO3-abolished VF (Figure 2a ). The incidences of other ventricular arrhythmias were also reduced in a concentration-dependent manner. If arrhythmias are ranked in a subjective order of severity (VF>VT> S>BG>VPB, where S is salvos and BG is bigeminy) it can be seen that NO3-substitution was proportionately more effective against the more severe arrhythmias, with increasingly higher NO3-concentrations required for inhibition of less severe arrhythmias (Figure 2a) . The mean latency to the onset of the first ischemiainduced arrhythmia (usually VPB) was not found to be altered by NCS (Figure 2b ).
Reperfusion-Induced Arrhythmias
Owing to the bell-shaped relation between susceptibility to reperfusion-induced arrhythmias and the duration of preceding ischemia,17 hearts were subjected to one of four durations of regional ischemia (5, 10, 15, or 30 minutes). NCS led to statistically significant concentration-dependent reductions in the incidences of reperfusion-induced VF ( Figure 3 ) and VT ( Figure 4 ) in hearts subjected to 10, 15, and 30 minutes of ischemia. The incidence of sustained VF was also reduced by NCS in a concentration-dependent manner ( Figure 5 ). To reveal the statistical significance of the latter effect it was necessary to "bin" data from hearts subjected to different durations of ischemia, owing to the low incidence of VF with high concentrations of NO3-( Figure  5 ). The less severe reperfusion-induced arrhythmias tended to be exacerbated by NCS (VPBs are shown in Figure 6 ), although this can be explained by "unmasking" as a consequence of the reduction in the incidence of VT and VF.
Reperfusion-induced arrhythmias in hearts subjected to 5 minutes of ischemia were affected differently. In controls, the incidences of arrhythmias were lower than in hearts reperfused after longer durations of ischemia and NCS had a concentration-dependent proarrhythmic effect. This trend was seen for all classes of arrhythmias; it was negligible in the case of VF ( Figure 3) and VT ( Figure 4 ) but was more evident for the less severe arrhythmias and reached statistical significance for VPB incidence ( Figure 6 ). In contrast to the situation with hearts reperfused after 10 or 15 minutes of ischemia (see above), the proarrhythmic effect on VPBs in hearts reperfused after 5 minutes of ischemia cannot be attributed to unmasking by inhibition of VT and VF, making the proarrhythmic effect unequivocal.
The latency to onset of the first reperfusion-induced arrhythmia was increased in a concentration-dependent manner by NCS in hearts reperfused after 10, 15, or 30 minutes of ischemia ( Figure 7) . However, in hearts reperfused after 5 minutes of ischemia, the opposite effect was seen, with increasing proportions of NO3-shortening the latency to onset of the first arrhythmia (Figure 7 ).
Heart Rate, Coronary Flow, and Occluded Zone Size
To determine whether the antiarrhythmic effects of NCS were some consequence of altered hemodynamics,
we measured heart rate and coronary flow throughout the experiment and occluded zone size at the end. Heart rate fell slightly during the course of the experiment in all groups (Table 1) . NCS had little effect on heart rate, and the Cl : NO3-ratio did not correlate with heart rate at any stage in the protocol (Table 1) . Not surprisingly, therefore, heart rate did not correlate with arrhythmia incidence.
NCS had a time-dependent effect on coronary flow, causing a progressive fall in the nonischemic region. This effect was concentration dependent (Figure 8 ).
Although the fall in flow occasionally reached statistical significance, there was no correlation between flow and arrhythmias (p =NS). Calculation of recovery of flow in the reperfused zone revealed a hyperemic response in control hearts reperfused after 5 or 10 minutes of ischemia (compare values in Figure 9 with equivalent values in the nonischemic region shown in Figure 8) , with a progressively smaller hyperemic response in control hearts reperfused after 15 or 30 minutes. NCS caused a concentration-dependent inhibition of the hyperemic response, such that recovery of coronary flow was significantly reduced by 100% NCS in hearts reperfused after 5 minutes of ischemia ( Figure 9) . A decline in hyperemic response occurred in controls during reperfusion after longer periods of ischemia (15 or 30 minutes). As a consequence, an antihyperemic effect of NCS was not demonstrable in hearts reperfused after 15 or 30 minutes of ischemia ( Figure 9 ). Despite their often being statistically significant, the effects of NCS on recovery of flow can be regarded as pathophysiologically unimportant with respect to the mechanism by which NCS inhibits reperfusion-induced VF, since there was no correlation between mean flow recovery and VF incidence (p=NS). Furthermore, there was no correlation between recovery of flow and latency to onset of the first reperfusion-induced arrhythmia; although recovery of flow (Figure 9 ) and arrhythmia onset ( Figure 6 ) were both delayed by NCS in hearts reperfused after 10 minutes of ischemia, the opposite was true in hearts reperfused after 5 minutes of ischemia (with arrhythmia onset occurring sooner despite a reduction in recovery of flow).
NCS had no effect on occluded zone size ( Figure  10 ). This was no surprise since collateral flow is negligible in rat hearts. 20 
ECG Changes
NCS had a triphasic effect on QRST9o ( Figure 11 ) that was dependent on when the values were recorded. Before the onset of ischemia, no changes were re- (Figure 11 ) produced by NCS (significant only in the 0:100 Cl-: NO3-group at 30 minutes after occlusion) failed to correlate with ischemia-induced arrhythmia incidence.
Assessment of the relation between ECG shape and reperfusion arrhythmias was complicated by the fact that arrhythmias appeared within a few seconds of the start of reperfusion and were sustained for variable periods; such censoring gave rise to data selection and unequal group sizes for ECG data. By 1 minute after the start of reperfusion there was considerable variation between groups in the numbers of hearts in which sinus rhythm had resumed. However, in the case of QRST90 width, clear differences between groups were evident, and values during reperfusion have been included in Figure 11 . Although reperfusion caused a rapid reversal of QRST90 widening, values remained significantly increased by NCS compared with preischemic values (particularly in the case of the 0:100 Cl-: NO3 group). Furthermore, QRST9O width correlated inversely with the incidence of reperfusion-induced VF (p<0.05). In the case of the PR interval, values during reperfusion have been omitted from Figure 11 owing to the large standard errors associated with diminished group size (especially in the all-Cl-controls), as explained above.
ECG intervals can be expected to be influenced by heart rate. We made no correction for heart rate in the present study, but none was required since NCS had no effect on heart rate ( 
Crossover Study With Global Ischemia
To assess whether effects of NCS on reperfusioninduced arrhythmias occurred as a result of actions during reperfusion or actions during the preceding periods of ischemia, crossover studies were performed in hearts subjected to 10 minutes of global ischemia. Atrial superfusion was maintained throughout the experiment. This kept the ventricular beating rate above 150 beats per minute throughout ischemia in all hearts. There were no significant differences between the four groups in terms of the incidence of reperfusion-induced VT. In hearts perfused before ischemia with 100:0 Cl-: NO3-solution and reperfused with this solution, the incidence was 100%, and in hearts perfused and reperfused with 0:100 Cl-: NO3 solution, the value was 83%. Similarly, values in hearts perfused with Cl-and reperfused with NO3-or vice versa were 75% and 92%, respectively. However, the incidence of VF was reduced by NCS. Furthermore, this required that NO3-be present during reperfusion. The VF incidence in the Cl-perfusion, Cl- 264+12 271+14 277+9  257+12  10  263+9  220+24 269+7  243+21 251+13  15  249+5  289+13 245+10 231+9  241+13  30   238+14 233+10 236+11 200+8  205+12 There were no statistically significant differences between anion ratio groups.
sequences of ischemia (via actions in the ischemic zone and the adjacent uninvolved zone) rather than by influencing the underlying causes of this dysfunction, the time course of its development, or ancillary variables (heart rate, coronary flow, and occluded zone size), which can determine or modify its extent and severity.
Actions of NCS on Reperfusion-Induced Arrhythmias The effects of NCS on reperfusion arrhythmias were dependent on the duration of preceding ischemia. In hearts subjected to 10, 15, or 30 minutes of ischemia, NCS reduced the incidences of reperfusion-induced VT and VF. As with ischemia-induced arrhythmias, there was no correlation between antiarrhythmic effects and antecedent hemodynamic variables (changes in heart rate, occluded zone size, or recovery of coronary flow during reperfusion). NCS reduced recovery of coronary flow in hearts reperfused after 5 or 10 minutes of ischemia; however, it has been shown previously that reductions over the range encountered in the present study do not affect reperfusion-induced arrhythmia incidence.14 The delayed onset of reperfusion-induced arrhythmias produced by NCS in hearts reperfused after 10, 15, or 30 minutes of ischemia was not related to recovery of flow.
In hearts reperfused after 5 minutes of ischemia (in which VT and VF incidence was low in control and NCS hearts), we observed a true proarrhythmic effect of NCS on VPB incidence. Thus, the so-called bell-shaped susceptibility curve (the relation between incidence of reperfusion-induced arrhythmias and duration of preceding ischemia) was shifted to the left by NCS. This was a paradox in view of the consistent antiarrhythmic effects against all types of arrhythmia observed during ischemia and against VT and VF during reperfusion after 10-30 minutes of ischemia. Changes in the shape or location of the bell-shaped curve give an indication of the mechanism of action of an antiarrhythmic intervention. For example, bradycardia shifts the curve to the right, indicative of an anti-ischemic action.39 Drugs that shift the curve downward (i.e., inhibit arrhythmias independently of the duration of preceding ischemia) can be regarded as having a specific action on the arrhythmogenic stimulus of reperfusion (most likely an electrophysiological action); the new antiarrhythmic R56865 appears to fall into this class. 40 In the present study, the shift in the curve substantially downward (VT and VF) and to the left (VPB) by NCS indicates either that NCS speeds up the time course of development of susceptibility to reperfusion-induced arrhythmias or that it has a selective effect on different arrhythmogenic triggers, inhibiting best those operative 10 or more minutes after the onset of ischemia but having no effect (or even facilitating) those operating with shorter (5-minute) durations of ischemia. Further work is required to elucidate which hypothesis is correct. Crossover perfusion studies with a model of global ischemia in which reperfusion-induced arrhythmias arise from within the reperfused zone14 showed that inhibition of reperfusion-induced arrhythmias by NCS resulted from a specific action on the arrhythmogenic Together, these data indicate that NCS inhibits reperfusion-induced arrhythmias via direct modification of the electrophysiological consequences of reperfusion mediated by an action in the reperfused tissue in a manner dependent on the underlying arrhythmogenic trigger mechanism (which varies according to the duration of preceding ischemia).
Insight Into Mechanism ofAction From Changes in the ECG
During ischemia, NCS widened the QRST9Q interval.
It has previously been shown that NCS can prolong action potential duration at 90% (and 50%) repolarization in papillary muscle.4' If widening of QRST9O by NCS reflects prolongation of action potential duration by NCS, then antiarrhythmic activity may have resulted from an associated prolongation of refractory period. However, this is unlikely to be the case because 1) drugs that produce significant widening of the QT interval, such as amiodarone, are not necessarily effective in preventing VF during ischemia or reperfusion in the rat heart42 and 2) tedisamil, an Ito blocker,43 has no effect on the incidence of VF in ischemia or reperfusion,44 despite its ability to widen the QRST interval in the rat heart to an even greater extent than did NCS in the 47 Because NCS prolongs action potential duration41 and QRST (the present study) and because substitution of extracellular Cl-by other anions can increase intracellular pH via alteration of ClV-HCO3-exchange,48 then it is possible that inhibition of Cl-HCO3-exchange may have contributed to the antiarrhythmic effects of NCS (via amelioration of ischemiainduced falls in intracellular pH and action potential duration shortening). This cannot be established directly because the ClV-HCO3-exchange current cannot be measured in a beating heart. However, in indirect support, recent studies have shown that specific blockers of ClV-HCO3-exchange such as SITS48 inhibit ischemia-induced and reperfusion-induced arrhythmias in the isolated rat heart.9
Contractile Function
We measured systolic and diastolic function in separate groups of hearts to examine whether the antiarrhythmic effects of NCS might be offset by a detrimental influence on contractile function. Over the normal range of end-diastolic pressure, NCS was without effect on contractility or compliance. However, at high "nonphysiological" end-diastolic pressures, EES was reduced by approximately 20% by total NCS. This effect, although statistically significant, was much less than that with verapamil (55% reduction). Furthermore, NCS had no effect on developed pressure at control end-diastolic volume, whereas verapamil produced a 72% reduction. The effect of NCS on EES possibly represents a "garden hose" mechanism, since in arrhythmia studies NCS caused a slight fall in coronary flow of similar magnitude to the change in EES, although we did not undertake to explore this possibility further. From these data we conclude that if anion manipulation represents a new approach to attenuation of arrhythmias in acute ischemia/reperfusion, it is not substantially compromised by any inherent negative influence on contractile function in nonischemic tissue. Nevertheless, from our data, the possibility remains that in the setting of more chronic cardiac dysfunction in which end-diastolic pressures are abnormally elevated (e.g., in heart failure), complete NCS may elicit a negative inotropic response and, possibly, hemodynamic compromise; in view of the potential benefits of anion manipulation against arrhythmias it would be worthwhile to perform in vivo studies to evaluate this possibility and to determine whether antiarrhythmic effects in the acute phase of ischemic heart disease can be achieved by anion manipulation without significant impairment of hemodynamic function.
Coronary Flow
The lack of NCS-induced vasodilatation was 1.2 versus 17.5-+±1 ml/min/g); this increase disappeared by 10 minutes (13.8+3 versus 13.9+1 ml/min/g, respectively). This tends to support the rapid tolerance hypothesis. However, it should be noted that our experiments are the first to examine coronary flow when NO3-is substituted for Cl-in the extracellular space, and this situation is not necessarily directly comparable to administration of organic NO3-compounds in the presence of fixed Cl-concentration, so substantial and sustained coronary vasodilation in the present study was not necessarily expected.
Was possible tolerance to NO3 vasodilatation relevant to the effects of NCS on arrhythmias? In terms of coronary flow changes, this would seem unlikely, since flows were within the normal range for the preparation, and coronary steal effects are not relevant with constant pressure perfusion.14 However, at the cellular level, NO3-tolerance may involve depletion of sulfhydryl moieties.50 Might this have some relevance to arrhythmogenesis? We doubt so, since N-acetylcysteine, an agent that has the opposite effect to NO3-and repletes cellular sulfhydryl levels via elevation of cysteine levels51 inhibits (rather than facilitates) arrhythmogenesis during ischemia and reperfusion in the rat. 52 
Species Considerations
Use of rat models for the study of arrhythmias and other responses to myocardial ischemia has recently been reviewed.27 It is clearly inappropriate to extrapolate findings from a single animal species to humans. As discussed in detail previously,8 rats have a faster basal heart rate and unusual cardiac electrophysiological characteristics (such as a short QT interval) compared with other species. Furthermore, phase 1 arrhythmias occur a few minutes later after the onset of ischemia in rat than in dog or pig and do not show well-defined 1A and 1B subpeaks.2,25,27 Regardless of these factors, in the rat, ischemia and reperfusion elicit arrhythmias that share characteristics and responsiveness to interventions that are broadly similar to arrhythmias elicited in other species; thus there is no a priori reason why rat arrhythmia data should be regarded as anomalous.17 '27 As noted previously,27 clinical relevance of any findings from rat (or indeed from any other animal species) can be proven only when the relevant clinical data become available. At present, direct data concerning the relation between anions and arrhythmogenesis in humans are lacking. The only available data are indirect53 and indicate that there is a strong association between a low incidence of sudden cardiac death (in certain regions of the United Kingdom) and high levels of NO3-in drinking water. 54 It has not been determined whether this association is casual or causal. We plan to explore this further by modifying anion content of rat Ischemia-induced VPB incidence fell from 100% to 50% with NCS, and reperfusion-induced VT incidence fell from 66% to 17%, findings similar to those from rat studies. However, V'F did not occur in either group, limiting the scope of findings.
Conclusion
VF elicited by ischemia could be almost fully abolished by NCS. The effect was not secondary to changes in heart rate, coronary flow, or occluded zone size, indicating an action mediated at the cellular level. Reperfusion-induced VF could also be almost fully abolished by NCS by an action mediated at the cellular level. The antifibrillatory effect depended on an action during reperfusion, was mediated in the reperfused region, and was unrelated to heart rate or recovery of coronary flow. In hearts reperfused after a very brief period of ischemia (5 minutes), the NCS increased the VPB incidence. NCS had no detrimental effects on systolic or diastolic function in nonischemic tissue. However, at abnormally high end-diastolic pressures, NCS had slight negative inotropic activity. NCS may represent the basis of a new antiarrhythmic approach.
